EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 128 filers reported holding EPIZYME INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,725,000 | -59.5% | 690,002 | -17.1% | 0.66% | -56.7% |
| Q3 2021 | $4,262,000 | -48.7% | 832,336 | -16.8% | 1.52% | -32.2% |
| Q2 2021 | $8,310,000 | -4.6% | 1,000,002 | 0.0% | 2.24% | +11.6% |
| Q1 2021 | $8,710,000 | -19.8% | 1,000,002 | 0.0% | 2.00% | -30.2% |
| Q4 2020 | $10,860,000 | +5.6% | 1,000,002 | +16.0% | 2.87% | +28.0% |
| Q3 2020 | $10,288,000 | -25.7% | 862,402 | 0.0% | 2.24% | -17.8% |
| Q2 2020 | $13,850,000 | +135.0% | 862,402 | +127.0% | 2.72% | +97.9% |
| Q1 2020 | $5,894,000 | -59.5% | 379,981 | -35.7% | 1.38% | -42.5% |
| Q4 2019 | $14,546,000 | -5.3% | 591,304 | -60.3% | 2.40% | -26.2% |
| Q3 2019 | $15,353,000 | -17.8% | 1,488,444 | 0.0% | 3.25% | -69.1% |
| Q2 2019 | $18,680,000 | +1.3% | 1,488,444 | 0.0% | 10.50% | +26.1% |
| Q1 2019 | $18,442,000 | +92.2% | 1,488,444 | -4.5% | 8.33% | +63.7% |
| Q4 2018 | $9,596,000 | -36.8% | 1,557,864 | +8.8% | 5.09% | -9.5% |
| Q3 2018 | $15,183,000 | -23.7% | 1,432,364 | -2.4% | 5.62% | -19.8% |
| Q2 2018 | $19,894,000 | -28.1% | 1,468,215 | -5.8% | 7.01% | -23.8% |
| Q1 2018 | $27,656,000 | +41.4% | 1,558,108 | 0.0% | 9.20% | +34.7% |
| Q4 2017 | $19,554,000 | -33.5% | 1,558,108 | +1.0% | 6.83% | -42.7% |
| Q3 2017 | $29,396,000 | +31.1% | 1,543,108 | +3.9% | 11.92% | +16.0% |
| Q2 2017 | $22,420,000 | -15.3% | 1,484,740 | -3.8% | 10.27% | -9.5% |
| Q1 2017 | $26,464,000 | +43.3% | 1,543,118 | +1.1% | 11.35% | +22.5% |
| Q4 2016 | $18,472,000 | +21.7% | 1,526,637 | -1.1% | 9.27% | +27.8% |
| Q3 2016 | $15,184,000 | +24.4% | 1,543,118 | +29.5% | 7.25% | -13.1% |
| Q2 2016 | $12,206,000 | -15.5% | 1,191,995 | 0.0% | 8.34% | +18.0% |
| Q1 2016 | $14,447,000 | -22.2% | 1,191,995 | +2.8% | 7.07% | +13.5% |
| Q4 2015 | $18,580,000 | +24.6% | 1,159,795 | 0.0% | 6.23% | +37.6% |
| Q3 2015 | $14,915,000 | -30.8% | 1,159,795 | +29.2% | 4.53% | -40.1% |
| Q2 2015 | $21,549,000 | +52.0% | 897,863 | +19.0% | 7.56% | -10.0% |
| Q1 2015 | $14,175,000 | +272.2% | 754,806 | +274.0% | 8.40% | +222.0% |
| Q4 2014 | $3,808,000 | – | 201,806 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |